We submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, issued by Parikh & Associates, Practicing Company Secretaries.
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, issued by Parikh & Associates, Practicing Company Secretaries. The report covers compliance with all applicable SEBI regulations including LODR 2015, ICDR, SAST, PIT, and Depositories regulations. The PCS has confirmed that the company maintained full compliance across all 14 check-points — no deviations, no penalties, and no enforcement actions were reported during the review period. The company has no subsidiaries (so material subsidiary requirements are not applicable), no employee stock option scheme, and no auditor resignations. All secretarial standards, website disclosures, board evaluations, and related party transaction protocols were found to be in order.
Clean compliance report with NIL observations — this is a positive signal for corporate governance and reinforces regulatory standing. No shareholder action is required.